ARCHIVES

Phase III Trial: Panobinostat Increases PFS by Four Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: D. Gary Gilliland Named President and Director of Fred Hutchinson Cancer Research Center

November 21, 2014

Crizotinib Eliminated Tumors In 7 of 8 Children with ALCL

May 25, 2012

NCI Programs: HMO Research Network wins $16 Million Grant for Prevention Studies

July 30, 1999

Also in this 8-page issue: Rep. James Greenwood to become president of Biotechnology Industry Association.

July 30, 2004

Professional Groups Agree On Colon Cancer Screening Guidelines.

March 7, 2008

ASCO Selects Three Cities For Quality Of Care Study.

June 2, 2000